tirzepatide cancer Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes and weight loss (Mounjaro, Zepbound)—can also shrink breast tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed tirzepatide mast cell Sensitized cells

Drinking adequate water throughout the day benefits both digestion and general health during Zepbound treatment

Roughly 40 million Americans carry FSA or HSA balances each year, yet many remain unaware that compounded GLP-1 medications qualify as eligible medical expenses

That is why each ladder step lasts at least 4 weeks the body needs that time to fully adjust

The results showed that LY3298176 had a dose-dependent effect on reducing HbA1c levels, and the reduction was greater than that achieved with dulaglutide or the placebo

However, its ability to promote significant weight loss has made it a game-changer in the obesity treatment landscape

Book an appointment and take the first step toward better health